1. Albeituni, S.H., Ding, C. & Yan, J. (2013) Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer. Cancer J., 19, 490-501.
2. Ayukawa, O., Nakamura, K., Kariyazono, H., Ikeda, R., Arima, J., Shinkawa, T., Iwase, H., Sakata, R. & Yamada, K. (2009) Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation. Blood Coagul. Fibrinolysis, 20, 176-184.
3. Ben-Meir, K., Twaik, N. & Baniyash, M. (2018) Plasticity and biological diversity of myeloid derived suppressor cells. Curr. Opin. Immunol., 51, 154-161.
4. Bramwell, K.K., Ma, Y., Weis, J.H., Chen, X., Zachary, J.F., Teuscher, C. & Weis, J.J. (2014) Lysosomal beta-glucuronidase regulates Lyme and rheumatoid arthritis severity. J. Clin. Invest., 124, 311-320.
5. Delahunt, B., Cheville, J.C., Martignoni, G., Humphrey, P.A., Magi-Galluzzi, C., McKenney, J., Egevad, L., Algaba, F., Moch, H., Grignon, D.J., Montironi, R. & Srigley, J.R. (2013) The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am. J. Surg. Pathol., 37, 1490-1504.